Gene · 388
Papers2,874
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 2,874
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Is miR-21 A Therapeutic Target in Cardiovascular Disease? | Int J Drug Discov Pharm | 2023 | 37799562 | PubTator, text mining | PubMed |
| S100PBP is regulated by mutated KRAS and plays a tumour suppressor role in pancreatic cancer. | Oncogene | 2023 | 37794133 | PubTator, text mining | PubMed |
| Phosphoprotein phosphatase activity positively regulates oligomeric pyrin to trigger inflammasome assembly in phagocytes. | mBio | 2023 | 37787552 | PubTator, text mining | PubMed |
| A Humanized Yeast System for Evaluating the Protein Prenylation of a Wide Range of Human and Viral CaaX Sequences. | bioRxiv | 2023 | 37786692 | PubTator, text mining | PubMed |
| Targeting cullin neddylation for cancer and fibrotic diseases. | Theranostics | 2023 | 37771770 | PubTator, text mining | PubMed |
| What Does the Future Hold for Biomarkers of Response to Extracorporeal Photopheresis for Mycosis Fungoides and Sézary Syndrome? | Cells | 2023 | 37759543 | PubTator, text mining | PubMed |
| Understanding the phenomenon of saltwater intrusion sourced from desalination plants at coastal aquifers. | Environ Sci Pollut Res Int | 2023 | 37759059 | PubTator, text mining | PubMed |
| miRNAs and Multiple Myeloma: Focus on the Pathogenesis, Prognosis, and Drug Resistance. | Technol Cancer Res Treat | 2023 | 37728167 | PubTator, text mining | PubMed |
| A comprehensive analysis of MYO6 as a promising biomarker for diagnosis, prognosis, and immunity in clear cell renal cell carcinoma. | Transl Cancer Res | 2023 | 37701098 | PubTator, text mining | PubMed |
| Quatramer™ encapsulation of dual-targeted PI3-Kδ/HDAC6 inhibitor, HSB-510, suppresses growth of breast cancer. | Bioeng Transl Med | 2023 | 37693068 | PubTator, text mining | PubMed |
| To stay in shape and keep moving: MLL emerges as a new transcriptional regulator of Rho GTPases. | Small GTPases | 2023 | 37671980 | PubTator, text mining | PubMed |
| Metabolic signature and proteasome activity controls synovial migration of CDC42hiCD14+ cells in rheumatoid arthritis. | Front Immunol | 2023 | 37662900 | PubTator, text mining | PubMed |
| Role of micro-RNAs 21, 124 and other novel biomarkers in distinguishing between group 1 WHO pulmonary hypertension and group 2, 3 WHO pulmonary hypertension. | Egypt Heart J | 2023 | 37646902 | PubTator, text mining | PubMed |
| Visualizing the subcellular localization of RHOB-GTP and GTPase-Effector complexes using a split-GFP/nanobody labelling assay. | Eur J Cell Biol | 2023 | 37639782 | PubTator, text mining | PubMed |
| Cell-in-cell: a potential biomarker of prognosis and a novel mechanism of drug resistance in cancer. | Front Oncol | 2023 | 37637068 | PubTator, text mining | PubMed |
| Deciphering the Functional Status of Breast Cancers through the Analysis of Their Extracellular Vesicles. | Int J Mol Sci | 2023 | 37629204 | PubTator, text mining | PubMed |
| BRAF Mutations in Melanoma: Biological Aspects, Therapeutic Implications, and Circulating Biomarkers. | Cancers (Basel) | 2023 | 37627054 | PubTator, text mining | PubMed |
| Pseudogenes in Cancer: State of the Art. | Cancers (Basel) | 2023 | 37627052 | PubTator, text mining | PubMed |
| Helicobacter pylori and epithelial mesenchymal transition in human gastric cancers: An update of the literature. | Heliyon | 2023 | 37609398 | PubTator, text mining | PubMed |
| Navigating the landscape of Rho GTPase signalling system in autoimmunity: A bibliometric analysis spanning over three decades (1990 to 2023). | Cell Signal | 2023 | 37598919 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/388/papers?page=9